Alurar rigakafin COVID-19 da Sinopharm ta kasar Sin ta samar don amfani da gaggawa, wanda WHO ta inganta.

Alurar rigakafin COVID-19 da Sinopharm ta kasar Sin ta samar

don amfani da gaggawa, wanda WHO ta tabbatar.

TheHukumar Lafiya ta Duniya (WHO)An inganta shi a ranar bakwai ga Mayu, rigakafin BBIBP-CorV COVID-19 wanda Sinopharm na kasar Sin ya samar don amfani da gaggawa.

A yammacin yau, WHO ta ba da jeri na amfani da gaggawa ga Sinopharm Beijing rigakafin COVID-19, wanda ya zama alurar riga kafi na shida don samun ingancin WHO don aminci, inganci da inganci," in ji Darakta-Janar na WHO Dr. Tedros Adhanom Ghebreyesus a wani taron manema labarai.

Wannan ya faɗaɗa jerin alluran rigakafin da COVAX za su iya saya, kuma yana ba ƙasashe kwarin gwiwa don hanzarta amincewar tsarin nasu, da shigo da gudanar da rigakafin.

 

Babban abin alfahari neMaganin gwajin endotoxin na Bioendoba da gudummawar wasu ƙoƙari don sarrafa ingancin gano endotoxin a cikin haɓakawa da samar da rigakafin COVID-19 a China.

Muna fata mutane a duk faɗin duniya za su ji daɗin lokacin kwanciyar hankali da rayuwa mai kyau.

 

Wannan labarin ya fito ne daga Labaran Bilingual Daily ta kasar Sin.